Some examples and use cases from the internet:

Some examples and use cases from the internet:

• All patients who developed PTLD were aged 18 years.
• Its safety and effectiveness have been studied in women aged 18 to 45 years.
• No major differences were observed for safety and efficacy in patients >= 65 years of age as compared to adults aged 18 to 65 years.
• fat meals in overweight adults, aged 18 or over.
• alli is used for weight loss alongside reduced calorie, lower
• The safety and efficacy has been established in women aged 18 to 45 years.
• 56% females) aged 18 to 65 for 6 days (to steady state).
• Adults, aged 18 or over, who are overweight.

• Paediatric patients PhotoBarr is not recommended for use in children below age 18 years due to a lack of data on safety and efficacy.
• Paediatric patients PhotoBarr is not recommended for use in children below age 18 years due to a lack of data on safety and efficacy.
• Special populations Children and adolescents (< 18 years) STELARA is not recommended for use in children below age 18 due to a lack of data on safety and efficacy.
• Aloxi is not recommended for use in children below age 18 due to insufficient data.
• ZIMULTI is not recommended for use in children below age 18 due to a lack of data on efficacy and safety.
• Risperidone is not recommended for use in children below age 18 with bipolar mania due to a lack of data on efficacy.
• Comtan is not recommended for use in children below age 18 due to lack of data on safety and efficacy.
• Comtess is not recommended for use in children below age 18 due to lack of data of safety and efficacy.